| Similar Articles |
|---|
 |
Chemistry World
August 1, 2012
Patrick Walter |
Phenomenal Olympic science legacy (or is that sustainability?) What do you do with a lab set up solely to catch Olympic drug cheats once the games are over? In the case of the London 2012 games, the answer is to turn it into a state of the art analytical lab.   |
Chemistry World
January 8, 2013
Andy Extance |
Phenome center move ends GSK role Running costs have forced the national MRC-NIHR Phenome Centre to move from the Harlow labs of pharmaceutical company GlaxoSmithKline, where it was originally going to be sited. |
Chemistry World
April 11, 2007
Victoria Gill |
A Dog's Life A group of dogs that enjoyed long lives on carefully planned diets has provided researchers with a unique life-long metabolic profile. The data reveal the relationship between diet, disease and longevity. |
Bio-IT World
July 14, 2004
Karen Hopkin |
'Omics: The NextGeneration Researchers in industry and academia are cataloging collections of biochemical compounds (metabolomics) to determine how they respond when organisms are challenged by drugs, disease, or stress (metabonomics). |
Bio-IT World
March 2007
Michael A. Greeley |
Can I Get Personal? VC's are back and seem very excited about the broader disease management and personalized medicine investment opportunities. |
Chemistry World
March 6, 2006
Katharine Sanderson |
Leap of Faith Pays Off for MR Research A new facility dedicated to studying clinical molecular resonance brings together clinicians and physicists to develop techniques for diagnosing and researching a range of diseases. |
Bio-IT World
April 2007
Kevin Davies |
The Human Metabolome Project Motivated by the absence of a metabolomic equivalent of GenBank that could provide information and possibly even samples of metabolites, researchers secured $7.5 million funding from Genome Canada in 2005 for the "Human Metabolome Project." |
Bio-IT World
November 14, 2003
Kathy Ordonez |
Targeted Medicine via Molecular Diagnostics Using diagnostics to select and deselect target populations for drug therapy will enable life scientists to make more effective medicines. |
Chemistry World
October 23, 2014
Andy Extance |
Agilent to exit NMR US-headquartered instrument maker Agilent Technology has stopped taking orders for new nuclear magnetic resonance spectrometers, leaving many within the chemistry community with tough choices. |
Bio-IT World
February 18, 2004 |
The Quest for Complex Genes Genetic sleuths are homing in on genes for complex diseases with the help of new, and some not so new, tools and strategies. |
Lucire
January 17, 2016 |
To your good health Alex Barrow flies to Malaysia to examine first-hand the phenomenon of medical tourism, and why the country is fast becoming the destination of choice |
Bio-IT World
May 2006
Robert M. Frederickson |
A New (Bio)Spin on NMR Applications Bruker BioSpin recently announced several introductions to improve throughput, sensitivity, and versatility of its systems for nuclear magnetic resonance applications starting with the SampleJet, a robotics system for high-throughput transfers of NMR sample tubes into the NMR spectrometer. |
Chemistry World
January 18, 2012
Patrick Walter |
Shell shutters UK R&D site The research currently carried out at the facility will be transferred to overseas sites. The announcement has fueled concerns in the UK research community that the country's opportunity to become a high-tech economy is slipping away. |
